Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Intervention with Therapeutic Agents, Understanding the Path to Remission to Type 2 Diabetes

Endocrinology and Metabolism Clinics of North America(2022)10.1016/j.ecl.2022.07.004Source: DataRank Database

Intervention with Therapeutic Agents, Understanding the Path to Remission to Type 2 Diabetes is a research paper published in Endocrinology and Metabolism Clinics of North America (2022). On theSindex it has a DataRank of 0. It has been cited 5 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access5 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 0.81)OA: greenTopics (32)IDs (PubMed, PMC, OpenAlex)Annotations (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (3)

Guillermo E. Umpierrez ORCID,Priyathama Vellanki ORCID,Shuai Hao ORCID

Live enrichment

PubMed:36754496 PMC:PMC10158502 OpenAlex:https://openalex.org/W4309634793

NIDDK NIH HHS

Grant: R03 DK129627

NIDDK NIH HHS

Grant: K23 DK113241

AstraZeneca

National Institutes of Health

FWCI

0.81

Citation Percentile

0.7%

Citation Trend

2023

2024

2025

greenLicense: http://www.elsevier.com/open-access/userlicense/1.0/

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC10158502/pdf/nihms-1891043.pdf

publisherhttps://api.elsevier.com/content/article/PII:S0889852922000743?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0889852922000743?httpAccept=text/plain

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/10158502

Fields of Study

Pharmacology and Obesity TreatmentDiabetes Treatment and ManagementDiet and metabolism studiesHumansDiabetes Mellitus, Type 2Glucagon-Like Peptide-1 ReceptorHypoglycemic AgentsWeight LossGlucagon-Like Peptide-1 Receptor Agonists

MeSH Terms

Glucagon-Like Peptide-1 ReceptorGlucagon-Like Peptide-1 Receptor AgonistsDiabetes Mellitus, Type 2HumansHypoglycemic AgentsWeight Loss

Keywords

MedicineIncretinType 2 diabetesWeight lossAgonistDiabetes mellitusGlucagon-like peptide-1Loss functionExenatideInternal medicineReceptorEndocrinologyObesityType 2 diabetes mellitusDiabetes RemissionΒ-cell PreservationDrug-free Remission

Intervention with Therapeutic Agents, Understanding the Path to Remission to Type 2 Diabetes

FAIR Checklist

Authors (3)

Funding (4 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)